2022
Alternative lengthening of telomeres in primary hepatic neoplasms
Yasir S, Thompson S, Chen Z, Knudson R, Knutson D, Kloft-Nelson S, Graham R, Jain D, Simon S, Wu T, Torbenson M. Alternative lengthening of telomeres in primary hepatic neoplasms. Human Pathology 2022, 131: 79-86. PMID: 36370823, PMCID: PMC10756352, DOI: 10.1016/j.humpath.2022.11.003.Peer-Reviewed Original ResearchConceptsPrimary hepatic neoplasmsPrimary hepatic angiosarcomaHepatocellular carcinomaHepatic neoplasmsHepatic angiosarcomaFibrolamellar carcinomaEpithelial tumorsNuclear pleomorphismFrequency of ALTStromal-epithelial tumorPrimary hepatic tumorsHepatocellular carcinoma componentMarked nuclear pleomorphismSoft tissue tumorsRare carcinosarcomaEmbryonal sarcomaEpithelioid hemangioendotheliomaDuct adenomaHilar cholangiocarcinomaCarcinoma componentHepatic adenomaHepatic tumorsTissue tumorsHepatocellular adenomaRhabdoid tumor
2011
Molecular Pathology of Hepatic Neoplasms: Classification and Clinical Significance
Walther Z, Jain D. Molecular Pathology of Hepatic Neoplasms: Classification and Clinical Significance. Pathology Research International 2011, 2011: 403929. PMID: 21559202, PMCID: PMC3090128, DOI: 10.4061/2011/403929.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsFocal nodular hyperplasiaHepatocellular carcinomaHepatocellular adenomaHepatic neoplasmsLiver cancerDysplastic nodulesMolecular classificationPrimary hepatic tumorsEarly hepatocellular carcinomaNovel therapeutic targetProgenitor cell phenotypeCommon malignancyPrognostic implicationsHCC-CCHepatic tumorsNodular hyperplasiaClinical significanceMolecular subtypesTherapeutic targetClinical practiceHepatic neoplasiaDistinct subtypesPatient careTumor phenotypeMolecular pathology